Market Tracker

04/17 6:05pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

7.57
Data as of Apr 17
 +0.02 / +0.26%
Today’s Change
5.47
Today|||52-Week Range
18.18
-49.50%
Year-to-Date

Today’s Trading

Previous close7.55
Today’s open7.54
Day’s range7.37 - 7.80
Volume1,263,739
Average volume (3 months)2,393,096
Market cap$932.4M
Dividend yield--
Data as of 4:00pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+32.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.02-0.49%
SZYMSolazyme Inc-0.23-2.01%
OPHTOphthotech Corp-0.06-0.19%
FMIFoundation Medicine ...-0.64-2.35%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 9, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts